Announcement
Silverwood Brands plc - Leading Balmonds product now available at Boots
RNS Number : 5742D
Silverwood Brands PLC
03 April 2025
3 April 2025
Silverwood Brands plc
("Silverwood", the "Company" or, together with its subsidiaries, the "Group")
Leading Balmonds product now available in Boots stores and on Boots.com
Silverwood Brands plc (AQSE: SLWD) is pleased to announce that Balmonds' flagship product, Skin Salvation, is now available in Boots stores and online at Boots.com.
Made with beeswax, organic oils and herbal tinctures, Skin Salvation is an award winning, 100% natural barrier balm, designed to prevent and treat the symptoms of eczema, psoriasis, and other dry skin conditions.
Alongside Skin Salvation, Balmonds produces a range of skin care solutions, including, creams, oils and salves, all based around natural and organic active ingredients. The Balmonds range is available directly from Balmonds.co.uk, as well as through channels including Amazon and Holland & Barrett. A wider range of Balmonds products will also be available soon on Boots.com.
Andrew Gerrie, Executive Director at Silverwood, said, "Balmonds is one of Silverwood's core brands. Its hero product, Skin Salvation, is now available in over 300 Boots stores, and on Boots.com.
Roughly 10% of people in the UK are estimated to have eczema at some point in their lives and at least 50% consider themselves as having sensitive skin. The addition of Boots to our distribution channels should help significantly increase the reach of Balmonds and our share of the market for sensitive skin solutions."
For more information, please contact:
|
Silverwood Brands Plc Andrew Gerrie Paul Hodgins
|
|
|
Peterhouse Capital Limited(Aquis Corporate Adviser) Mark Anwyl Narisha Ragoonanthun Brefo Gyasi
|
+44 (0)20 7469 0930 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFXLFBEZLXBBB
;